IMPROTA, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 3.965
EU - Europa 787
AS - Asia 385
SA - Sud America 42
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.186
Nazione #
US - Stati Uniti d'America 3.939
IN - India 224
UA - Ucraina 189
SE - Svezia 187
IT - Italia 148
FI - Finlandia 133
CN - Cina 108
SG - Singapore 51
AR - Argentina 39
GB - Regno Unito 36
IE - Irlanda 26
BG - Bulgaria 22
CA - Canada 20
DE - Germania 13
BE - Belgio 11
NL - Olanda 7
AT - Austria 5
MX - Messico 5
CH - Svizzera 3
CL - Cile 3
EU - Europa 3
RO - Romania 3
RU - Federazione Russa 3
ZA - Sudafrica 3
IR - Iran 1
KZ - Kazakistan 1
MU - Mauritius 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 5.186
Città #
Fairfield 620
Chandler 420
Ashburn 345
Woodbridge 327
Houston 235
Seattle 234
Wilmington 202
Cambridge 197
Ann Arbor 169
Princeton 125
Plano 122
San Paolo di Civitate 121
Beijing 101
Jacksonville 85
Lawrence 72
Boston 60
San Diego 52
Federal 39
Andover 35
Des Moines 32
Boardman 30
Dublin 25
Norwalk 25
Millbury 24
Singapore 24
Rome 22
Sofia 22
Toronto 14
Washington 13
Brussels 11
Falls Church 11
Helsinki 11
Indiana 11
Auburn Hills 10
Dearborn 9
Los Angeles 9
Bühl 6
Buffalo 5
Vienna 5
Mannheim 4
Montréal 4
Redmond 4
Bern 3
Chicago 3
London 3
Monterrey 3
Muizenberg 3
San Mateo 3
Laurel 2
Mexico City 2
New York 2
Philadelphia 2
Southend 2
Almaty 1
Amsterdam 1
Catford 1
Fayetteville 1
Frankfurt Am Main 1
Fremont 1
Fuzhou 1
Gorey 1
Hangzhou 1
Hefei 1
Hounslow 1
Kunming 1
Kyiv 1
Leawood 1
Mcallen 1
Milan 1
Montreal 1
Munich 1
Nanjing 1
Ningbo 1
Oslo 1
Ottawa 1
Peterborough 1
Phoenix 1
Pune 1
Redwood City 1
San Francisco 1
San Juan 1
Santa Clara 1
Santiago 1
Seversk 1
Stockholm 1
Tappahannock 1
Trumbull 1
Yellow Springs 1
Totale 3.955
Nome #
Neuropeptide S inhibits stress-stimulated faecal output in the rat 103
A rat model of narcotic bowel syndrome 99
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors 93
TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat 82
The hypothalamus-pituitary-adrenal axis does not influence the protective effects of nociceptin/orphanin FQ on the rat gastric mucosa. 82
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 78
Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion 76
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis 73
TLQP-21, a VGF-derived peptide, prevents ethanol-induced gastric lesions: Insights into its mode of action 70
Expression of NK-1 and NK-3 tachykinin receptors in pancreatic acinar cells after acute experimental pancreatitis in rats. 69
Sauvagine-induced hypothermia: evidence for an interaction with the dopaminergic system. 68
The brain-gut-skin triangle: New peptides 67
Central and peripheral role of the nociceptin/orphaninFQ system on normal and disturbed colonic motor function and faecal pellet output in the rat 65
Central and peripheral antiulcer and antisecretory effects of Ala(5)NKA(4-10), a tachykinin NK2 receptor agonist, in rats 64
Effect of caerulein infusion on glucagon secretion in the dog. 64
Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differences 63
In vitro and in vivo opioid activity of [DPro(6)]dermorphin, a new dermorphin analogue 63
EFFECT OF SELECTIVE MU(1), MU(2) AND DELTA(2) OPIOID RECEPTOR AGONISTS ON GASTRIC FUNCTIONS IN THE RAT 63
The mechanism of the antidiuretic effect of sauvagine in rats 62
Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig 62
Role of cannabinoid system in the exocrine pancreas 59
Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII 59
Evidence of Central and Peripheral Sensitization in a Rat Model of Narcotic Bowel-Like Syndrome 59
Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide. 59
Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats 58
Adrenal Modulation of the Inhibitory Effect of Sauvagine On Gastric-emptying 58
The Effect of [Leu8]Litorin, a New Bombesin-like Peptide, on Gastric Functions and Thermoregulation in the Rat 58
Expression of NK-1 and NK-3 tachykinin receptors in pancrestic acinar cells after acute experimental pancreatitis in rats 57
The tachykinin peptide family 57
The effects of [Arg(14), Lys(15)] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions 56
TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat 56
Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis 56
Spinal Antinociceptive Effects of [d-ala2]deltorphin-ii, A Novel and Highly Selective Delta-opioid Receptor Agonist 56
Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats 54
Immunocytochemical distribution of NK-1 and NK-3 tachykinin receptors in isolated pancreatic acini of guinea pigs and rats 54
Sauvagine: effects on gastric acid secretion in rats. 54
Tachykinins - Effects On Gastric-secretion and Emptying In Rats 54
Gastric antisecretory effect of sauvagine in rats: Possible mechanisms 54
Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: A comparative study 54
Effect of sauvagine on gastric emptying in conscious rats. 53
CROSS-TOLERANCE BETWEEN DERMORPHIN AND MORPHINE TO ANALGESIA AND CATALEPSY IN RATS 53
Antidiarrheal effect of deltorphin II, a highly selective delta opioid receptor agonist, in the rat. 53
Evidence of cholecystokinin release by bombesin in the dog 52
Antinociceptive effect of two amphibian tachykinins, PG-SPI and PG-KII, in the rat tail-flick test. 51
Tachykinins: Role in human gastrointestinal tract physiology and pathology 51
Maternal Exposure to Low Levels of Corticosterone during Lactation Protects against Experimental Inflammatory Colitis-Induced Damage in Adult Rat Offspring 51
Anti-hyperalgesic effect of nociceptin/orphanin FQ in a rat model of narcotic bowel syndrome 50
Effect of PG-SPI and PG-KII, two novel and natural tachykinins, on salivary secretion in the rat 50
Effects of dermorphin on gastrointestinal transit in rats 50
Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin 48
Distribution and metabolism of dermorphin in rats 48
Sauvagine: inhibition of gastric acid secretion in rats. 48
Effects of supraspinal administration of PG-SPI and PG-KII, two amphibian tachykinin peptides, on nociception in the rat 47
Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors 47
Central effects of selective NK1 and NK3 tachykinin receptor agonists on two models of experimentally-induced colitis in rats 47
The role of caudate nucleus in dermorphin-induced catalepsy in rats. 46
Evolutionary aspects in the peripheral peptidergic signals: CRF-like peptides and modulation of G.I. functions. 46
Central Neuropeptide S inhibits stress-stimulated defecation in the rat 45
The action of gantrisin [N'-(3,4-dimethyl-5-isoxazolyl)sulfanilamide] on the oedema-forming and muscle-stimulating activity of eledoisin and physalaemin. 45
The effects of UFP112, a novel N/OFQ-NOP receptor ligand, on colonic propulsion and defecation in physiological and pathological conditions 44
Anti-nociceptive effects of orphanin FQ in inflammation-induced hyperalgesia in rat 44
Orphanin FQ/nociceptin: effects on gastric acid secretion and emptying in rats. 43
Neural regulation of gastric acid secretion in rats: Influence of dermorphin 43
Farmacologia, azione e reazione dei farmaci 41
Parallel bioassay of bombesin and litorin, a bombesin-like peptide from the skin of Litoria aurea. 41
In vitro and in vivo biological activities of PG-KII, a novel kassinin-like peptide from the skin of the Australian frog, Pseudophryne guntheri 40
Phyllolitorins: A New Family of Bombesin-like Peptides 40
Amphibian Tachykinins 37
A rat model of narcotic bowel syndrome 37
Tolerance and physical dependence induced by dermorphin in rats 37
HS-599: a novel long acting opioid analgesic does not induce place-prefence in rats 36
Role of tachykinin NK3 receptor agonists in the control of pancreatic exocrine secretion in vitro 35
The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions 35
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity 34
N/OFQ and NOP receptor system: role in the control of some gastrointestinal activities in physiological and pathological conditions. 32
STIMULATORY EFFECT OF PG-KII, AN NK3 TACHYKININ RECEPTOR AGONIST, ON ISOLATED PANCREATIC ACINI:SPECIES DIFFERENCES. 32
Immunomodulatory role of nociceptin/orphanin FQ - NOP receptor system in a rat model of experimental colitis 32
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide in the regulation of rat motor gastric functions 32
In vitro and in vivo effects of WIN55,212 on exocrine pancreas in physiological condition and during acute pancreatitis 31
Antidiarrheal and Colonic Antipropulsive Effects of Spinal and Supraspinal Administration of the Natural Delta-opioid Receptor Agonist, [d-ala(2)]deltorphin-ii, In the Rat 31
A MODEL OF NARCOTIC BOWEL SYNDROME IN RATS: EVIDENCE OF CENTRAL AND PERIPHERAL SENSITIZATION 31
Central effect of two natural tachykinins, PG-SPI and PG-KII, on experimental colitis in rats. 31
Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse 31
Role of delta opioid receptor system in the control of colonic propulsion in rats and mice 30
A comparative study of the effect of (Arg14,Lys15)N/OFQ and deltorphin on exocrine pancreatic secretion in vitro 30
A comparative study of the effect of (Arg 14, Lys 15)N/OFQ and deltorphin on exocrine pancreatic secretion in vitro. 29
Effect of two amphibian tachykinins, PG-SPI and PG-KII, on different models of experimental colitis in rats. 29
Effect of maternal exposure to low levels of corticosterone during lactation on the susceptibility to the TNBS-induced colitis in rat adult male and female offspring 29
The effects of Arg14 Lys15 nociceptin/orphanin FQ, a higly potent agonist of the NOP receptor, on invitro and in vivo gastrointestinal functions. 28
INTERACTION BETWEEN THE MU-AGONIST DERMORPHIN AND THE DELTA-AGONIST [D-ALA(2), GLU(4)]DELTORPHIN IN SUPRASPINAL ANTINOCICEPTION AND DELTA-OPIOID RECEPTOR-BINDING 28
Novel dermorphin analogues: in vitro and in vivo gastrointestinal effects. 28
Disappearance of caerulein from circulating blood and its inactivation in vitro by tissue homogenates and blood of dogs and rats. 28
The central and peripheral effects of UFP112, a novel N/OFQ-NOP receptor ligand, on colonic propulsion and defecation in physiological and pathological conditions 27
Involvement of the cannabinoid system in the rat and guinea pig exocrine pancreatic secretion. 27
Peripheral antinociceptin effect of orphanin/FQ on postinflammatory colorectal hypersensitivity is mediated by an up regulation of N/OFQergic system 27
Effect of a natural NK1 tachykinin receptor agonist, PG-SPI, on two models of experimental colitis in rats. 26
Role of the cannabinoid system in the exocrine pancreas 26
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat motor gastric functions 26
Sauvagine, a new polypeptide from Phyllomedusa sauvagei skin. Occurrence in various Phyllomedusa species and pharmacological actions on rat blood pressure and diuresis. 25
Nociceptin/orphaninFQ-induced gastric emptying delay: evidence for a role of limbic-adrenal axis 24
Totale 4.856
Categoria #
all - tutte 13.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 110
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019462 0 0 0 0 0 0 0 0 0 0 268 194
2019/20201.257 215 48 13 68 125 125 143 148 139 113 84 36
2020/2021357 52 53 15 34 9 23 6 41 42 49 23 10
2021/20221.042 5 86 114 11 136 20 22 124 96 100 129 199
2022/20231.268 217 259 92 162 134 154 11 56 140 3 27 13
2023/2024343 38 72 19 42 28 60 4 8 0 47 25 0
Totale 5.234